Frequent epigenetic silencing of PCDH10 by methylation in human colorectal cancer
- 22 November 2012
- journal article
- research article
- Published by Springer Science and Business Media LLC in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 139 (3), 485-490
- https://doi.org/10.1007/s00432-012-1353-5
Abstract
Aberrant DNA methylation is common in cancer cells. Epigenetic alterations resulting in the loss of tumor suppression gene functions are frequently involved in tumor development and progression. Recently, methylation of PCDH10 was reported to be associated with multiple hematologic malignancies as well as some solid tumors. Whether the down-regulation of PCDH10 happens in CRC remains unknown. Methylation status of PCDH10 was evaluated by methylation-specific PCR analysis. The effects of PCDH10 re-expression were determined in growth, colony formation, cell cycle, and invasion assays. In this study, we found that 100 % (8 of 8) of colorectal cancer cell lines were silenced for PCDH10, but not normal colorectal epithelial cells. Demethylation treatment confirmed that the reduced expression is associated closely with promoter methylation. Hyper-methylation of PCDH10 was also detected in 85 % of primary colorectal tumors, but not in adjacent normal colorectal tissues. Our results suggest that PCDH10 is an important tumor suppression gene with key roles of suppressing cell proliferation, clonogenicity, and inhibiting cell invasion in the development of colorectal cancer. Thus, PCDH10 methylation may constitute a useful biomarker of colorectal cancer patients.This publication has 24 references indexed in Scilit:
- Role of PCDH10 and its hypermethylation in human gastric cancerBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2012
- Cadherins and cancer: how does cadherin dysfunction promote tumor progression?Oncogene, 2008
- Cancer epigenomics: DNA methylomes and histone-modification mapsNature Reviews Genetics, 2007
- Frequent epigenetic silencing of protocadherin 10 by methylation in multiple haematologic malignanciesBritish Journal of Haematology, 2007
- Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylationOncogene, 2005
- Transformation of immortalized colorectal crypt cells by microcystin involving constitutive activation of Akt and MAPK cascadeCarcinogenesis: Integrative Cancer Research, 2005
- Gene Silencing in Cancer in Association with Promoter HypermethylationThe New England Journal of Medicine, 2003
- The power and the promise of DNA methylation markersNature Reviews Cancer, 2003
- ProtocadherinsCurrent Opinion in Cell Biology, 2002
- MICROCYSTINS (CYANOBACTERIAL TOXINS) IN DRINKING WATER ENHANCE THE GROWTH OF ABERRANT CRYPT FOCI IN THE MOUSE COLONJournal of Toxicology and Environmental Health, Part A, 2000